Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FVWM8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,016
Award facts
- Contract value 100% obligated
- $11,016.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,016.48 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Dupixent 300 mg/2 ml pen injections. This firm fixed-price delivery order was executed on August 27, 2025, with an ultimate completion date of August 28, 2025, and carries no set-aside designation. The award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at approximately $500 million and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities nationwide.
DMS Pharmaceutical Group has established itself as a significant supplier within the federal pharmaceutical supply chain through its registered woman-owned small business status and robust portfolio of pharmaceutical distribution contracts with the Department of Defense. The company specializes in providing branded and generic prescription medications, biologics, and medical consumables to military and federal healthcare systems. This particular delivery order for Dupixent, a prescription injectable medication, exemplifies the company's core business of distributing specialized pharmaceutical products to support the medical supply needs of Defense Department healthcare facilities.
Quick answers
Who was awarded contract SPE2DB25FVWM8?
SPE2DB25FVWM8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FVWM8 worth?
The government has obligated $11,016 on SPE2DB25FVWM8.
Is contract SPE2DB25FVWM8 an order under another contract?
Yes. SPE2DB25FVWM8 is a delivery order under SPE2DB24D9120, an indefinite delivery contract.
Was contract SPE2DB25FVWM8 competed?
The extent of competition for SPE2DB25FVWM8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award